INPHARMATIS: Readability user testing is requested in EAEU

October 15, 2020

Readability user testing is requested in EAEU

Does your company know that User Testing of Patient Information Leaflet (PIL testing/ Readability user testing (RUT)) of medicines is requested in EAEU region according to decision of the Eurasian Economic Commission (EEC) No. 88.?

To conduct PIL testing, you should:

be familiar with the EAEU rules
have appropriate experience in local markets
be able to perform testing in EAEU acceptable language.

Inpharmatis is an international consulting company with more than 15 years’ experience in EAEU, CIS and EU markets in the field of regulatory services for pharmaceutical companies.

We are delighted to propose PIL testing in EAEU performed by Inpharmatis - leading provider with great practical experience and expertise of PIL testing in EAEU region.

Inpharmatis has been involved with readability testing since the beginning of the EU requirement in 2005.

We offer:

PIL EAEU expertise according to EAEU requirements (also based on previous successful EU experience)
Guaranteed Acceptance Across the EAEU requirements
Bridging studies for readability user testing
Highly qualified multilanguage User Testing Project team located in each country of EAEU
PIL GAP analysis versus requirements of EEC Decision No. 88.
EU or National PIL reformatting according to EAEU requirements
PIL and SmPC translation to most EAEU languages
Quick implementation of the project
Conduct the validated Readability User Testing in EAEU acceptable languages
Validated quality procedures
Flexible price